Picard Medical is trading 7.19% higher at $8.95, with broad market gains the clearest available explanation; no fresh company-specific announcement was identified. - U.S. futures rose as oil prices fell and technology recovered after last week’s selloff. - Major indices were also higher in the provided market context, making broad risk-on sentiment clearest rather than a confirmed company catalyst. - Recent closes show a sharp run-up, including gains on October 28 and October 29; no trading-volume data was provided.